Trial Profile
A Clinical Trial of the Safety and Efficacy of ABX-EGF in Combination With Irinotecan, Leucovorin, and 5-Fluorouracil in Subjects With Metastatic Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Irinotecan (Primary) ; Panitumumab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 30 Oct 2008 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 18 Sep 2005 New trial record.